Research & Development

The landscape of cancer care is undergoing a profound transformation with the advent of cutting-edge technologies that promise to redefine treatment precision and patient experience. At the forefront of this revolution stands the Huntsman Cancer Institute at the University of Utah, which has

Could a single enzyme hold the key to transforming outcomes for one of the deadliest cancers known to medicine? Pancreatic cancer, with its dismal survival rates and relentless spread, claims countless lives each year, often leaving patients and families with little hope. Yet, a groundbreaking

In the ever-evolving landscape of healthcare, where technology and patient care intersect, few individuals stand out as prominently as David Mulherin, a clinical informatics pharmacist and lead application analyst at Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee. His

In the heart of Washtenaw County, Michigan, a small yet profoundly affected community of roughly 107 individuals battles the relentless challenges of sickle cell disease (SCD), a genetic blood disorder that inflicts severe pain and life-threatening complications on those diagnosed. Primarily

In a significant stride toward combating advanced lung cancer, the U.S. Food and Drug Administration has granted Fast Track designation to a promising new therapy known as AVZO-1418, also referred to as DB-1418. This innovative treatment targets patients with unresectable, locally advanced, or

Imagine a patient facing major surgery, anxious about the risks and uncertain about recovery, only to discover that a tailored preparation plan could dramatically lower complications and improve outcomes. This isn’t a far-off dream but a reality backed by groundbreaking research from a leading